太陽國際(08029.HK):290.5萬股要約股份獲有效接納 要約結束
格隆匯11月1日丨太陽國際(08029.HK)公佈,紅日資本有限公司為及代表要約人作出的要約於2021年11月1日(星期一)下午四時正(香港時間)結束。要約人並無修訂或延長。
於2021年11月1日(星期一)下午四時正(香港時間)(為要約的最後接納日期及時間),要約人已接獲要約下就290.5萬股要約股份的有效接納,相當於聯合公吿日期全部已發行股份約0.13%。
緊隨要約結束後,並計及290.5萬股要約股份的有效接納,要約人及其一致行動人士於合共約14.38億股股份擁有權益,相當於聯合公吿日期全部已發行股份約62.95%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.